Neumora Therapeutics Files S-8 for Employee Stock Plans

TL;DR

Neumora just filed an S-8 for employee stock plans - means they're ready to issue shares to their team!

AI Summary

Neumora Therapeutics, Inc. filed an S-8 form on March 30, 2026, to register securities for offering under employee benefit plans. This filing indicates the company is making shares available to its employees, likely as part of compensation or incentive programs. The filing does not involve a sale of securities to the public but rather the registration of shares for internal distribution.

Why It Matters

This filing allows Neumora Therapeutics to issue stock to employees, which can be a key tool for attracting and retaining talent in the competitive biotech sector.

Risk Assessment

Risk Level: low — An S-8 filing is a routine registration of securities for employee benefit plans and does not inherently represent new financial risk for the company or investors.

Key Numbers

• 2026-03-30 — Filing Date (Date Neumora Therapeutics, Inc. submitted the S-8 form.)

Key Players & Entities

• Neumora Therapeutics, Inc. (company) — Filer of the S-8 registration statement
• 0001885522 (company) — CIK number for Neumora Therapeutics, Inc.
• March 30, 2026 (date) — Filing date and effectiveness date of the S-8 form
• 333-294723 (dollar_amount) — File number associated with the S-8 filing

FAQ

Key Financial Figures

• $0.0001 — ) 8,713,016 shares of its common stock, $0.0001 par value (the “Common Stock&#x2

Filing Documents

• nmra-20260330.htm (S-8) — 145KB
• nmra-ex5_1.htm (EX-5.1) — 21KB
• nmra-ex23_2.htm (EX-23.2) — 4KB
• nmra_exfilingfees.htm (EX-FILING FEES) — 38KB
• img215949864_0.jpg (GRAPHIC) — 48KB
• img215949864_1.jpg (GRAPHIC) — 18KB
• 0001193125-26-130407.txt ( ) — 435KB
• nmra_exfilingfees_htm.xml (XML) — 12KB

Incorporation of Documents by Reference

Item 3. Incorporation of Documents by Reference. The SEC allows us to incorporate by reference the information we file with them, which means that we can disclose important information to you by referring you to those documents. The information incorporated by reference is considered to be part of this Registration Statement, and later information filed with the SEC will update and supersede this information. We hereby incorporate by reference into this Registration Statement the following documents previously filed with the SEC: • the contents of the Registrant’s earlier Registration Statements on Form S-8 relating to the 2023 Plan and ESPP, previously filed with the SEC on March 3, 2025 (File No. 333-285507 ), March 7, 2024 (File No. 333-277748 ) and September 20, 2023 (File No. 333-274593 ); • the Registrant’s Annual Report on Form 10-K for the year ended December 31, 2025, filed with the SEC on March 30, 2026 ; • the Registrant’s Current Reports on Form 8-K filed with the SEC on January 5, 2026 ; • the description of the Common Stock contained in the Registrant’s registration statement on Form 8-A (File No. 001-41802 ), filed by the Registrant with the SEC under Section 12(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), on September 13, 2023, including any amendments or reports filed for the purpose of updating such description. All documents that the Registrant subsequently files pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act prior to the filing of a post-effective amendment to the registration statement which indicates that all of the shares of Common Stock offered have been sold or which deregisters all of such shares then remaining unsold shall be deemed to be incorporated by reference in this Registration Statement and to be a part hereof from the date of the filing of such documents, except as to any portion of any future annua

Exhibits

Item 8. Exhibits. Exhibit Number Incorporated by Reference Filed Exhibit Description Form Date Number Herewith 4.1 Amended and Restated Certificate of Incorporation, as amended, currently in effect. 8-K 9/19/23 3.1 4.2 Bylaws, as amended, currently in effect. 8-K 9/19/23 3.2 4.3 Form of Common Stock Certificate. S-1/A 9/11/23 4.2 5.1 Opinion of Latham & Watkins LLP. X 23.1 Consent of Latham & Watkins LLP (included in Exhibit 5.1). X 23.2 Consent of Ernst & Young LLP, independent registered public accounting firm. X 24.1 Power of Attorney. Reference is made to the signature page to the Registration Statement. X 99.1# 2023 Incentive Award Plan. S-8 9/19/23 99.3(a) 99.2# Form of Stock Option Grant Notice and Stock Option Agreement under the 2023 Incentive Award Plan. S-1 8/25/23 10.7(b) 99.3# Form of Restricted Stock Unit Award Agreement under the 2023 Incentive Award Plan. S-1 8/25/23 10.7(c) 99.4# 2023 Employee Stock Purchase Plan. S-8 9/19/23 99.4 107.1 Filing Fee Table. X # Indicates management contract or compensatory plan.

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in City of Watertown, Commonwealth of Massachusetts, on this 30 th day of March 2026. Neumora Therapeutics, Inc. By: /s/ Paul L. Berns Name: Paul L. Berns Title: Chief Executive Officer POWER OF ATTORNEY KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below does hereby constitute and appoint Paul. L Berns and Michael Milligan, and each of them, with full power of substitution and full power to act without the other, as his or her true and lawful attorney-in-fact and agent to act for him or her in his or her name, place and stead, in any and all capacities, to sign any and all amendments (including post-effective amendments) to this Registration Statement, and to file this Registration Statement, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in order to effectuate the same as fully, to all intents and purposes, as they or he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or any of them, may lawfully do or cause to be done by virtue hereof. Pursuant to the requirements of the Securities Act of 1933, as amended, this Registration Statement has been signed by the following persons in the capacities and on the date indicated. Signature Title Date /s/ Paul L. Berns Paul L. Berns Chief Executive Officer and Chairman of the Board of Directors (Principal Executive Officer) March 30, 2

View Full Filing

View this S-8 filing on SEC EDGAR